Shariah compliance overview
Not HalalEikon Therapeutics, Inc. Common Stock (EIKN) is currently classified as Not Halal by Akinda Shariah screening (AAOIFI-aligned methodology).
About Eikon Therapeutics, Inc. Common Stock
Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established in 2019 and headquartered in Millbrae, California, operating within the United States. The company is dedicated to developing groundbreaking medicines to address significant unmet medical needs.
Eikon Therapeutics, Inc. Common Stock (EIKN) operates in the Healthcare sector, in the Biotechnology industry.
Why it is not classified as halal: it does not pass these screens: Business Activity, Interest-bearing debt, Interest-bearing securities and assets.
- Business Activity
- 100.00%Limit 5%Fail
- Interest-bearing debt
- 52.51%Limit 30%Fail
- Interest-bearing securities and assets
- 50.31%Limit 30%Fail
- Dividend purification
- 100.00%Share of dividends to give to charityPurification calculator
Last updated: Nov 20, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.
Please login to access this content
Please login to access this content
Please login to access this content
Company Profile
Please login to access this content
Frequently asked questions
Quick answers about Eikon Therapeutics, Inc. Common Stock (EIKN). Current Akinda screening label: Not Halal.
